InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Chan Mitchell. Director active across 2 companies, notably Avalo Therapeutics, Inc.. Aggregated, 3 reports have been recorded. Activity tracked since 16 September 2024. The latest transaction was disclosed on 16 September 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
3 of 3 declarations